Usana Health Sciences
USNA
180 hedge funds and large institutions have $994M invested in Usana Health Sciences in 2021 Q3 according to their latest regulatory filings, with 18 funds opening new positions, 55 increasing their positions, 69 reducing their positions, and 24 closing their positions.
0.89% less ownership
Funds ownership: 54.8% → 53.91% (-0.89%)
4% less funds holding
Funds holding: 188 → 180 (-8)
12% less capital invested
Capital invested by funds: $1.13B → $994M (-$141M)
20% less repeat investments, than reductions
Existing positions increased: 55 | Existing positions reduced: 69
25% less first-time investments, than exits
New positions opened: 18 | Existing positions closed: 24
60% less call options, than puts
Call options by funds: $841K | Put options by funds: $2.1M
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Pzena Investment Management
New York
|
+$9.21M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$3.99M |
| 3 |
Pacer Advisors
Malvern,
Pennsylvania
|
+$3M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$2.62M |
| 5 |
SG Americas Securities
New York
|
+$2.32M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$9.78M |
| 2 |
Acadian Asset Management
Boston,
Massachusetts
|
-$6.27M |
| 3 |
Goldman Sachs
New York
|
-$5.2M |
| 4 |
BlackRock
New York
|
-$3.08M |
| 5 |
Russell Investments Group
London,
United Kingdom
|
-$2.76M |
USNA Hedge Fund Activity: Q3 2021 in Review
180 of the 5,713 institutional investors tracked by Wall St. Rank reported a position in Usana Health Sciences (USNA) for Q3 2021, worth a combined $994M — down 12% from $1.13B a quarter earlier.
Sellers outnumbered buyers: 24 funds closed out of USNA and 18 opened new positions — a net loss of 6 holders — while 69 trimmed existing stakes and 55 added.
The largest buyer was Pzena Investment Management, opening a new position worth an estimated $9.21M. The largest seller was Arrowstreet Capital, cutting an estimated $9.78M.
- 180 institutional investors held Usana Health Sciences (USNA) as of Q3 2021, down from 188 in Q2 2021.
- Funds reported $994M of Usana Health Sciences stock for Q3 2021, down 12% quarter-over-quarter.
- 18 funds opened new Usana Health Sciences positions in Q3 2021 and 24 closed out, a net change of -6 holders.
- The largest Usana Health Sciences buyer in Q3 2021 was Pzena Investment Management, an estimated $9.21M added.
- The largest Usana Health Sciences seller in Q3 2021 was Arrowstreet Capital, an estimated $9.78M sold.
Based on aggregated 13F filings for Q3 2021.